September 17, 2014

An analysis done by the CVS Health Research Institute provides insights regarding patients taking Sovaldi (sofosbuvir), a new and costly treatment for hepatitis C.

September 16, 2014

More than 75 locally-owned community pharmacies throughout Arkansas are enhancing patient care by participating in a unique nine-month medication adherence program.

September 16, 2014

In this special diabetes report, DSN covers the latest innovation in the diabetes sector from wearable technology to prescription drugs to devices to pharmacist care for diabetic patients.

September 15, 2014

Community pharmacists can dramatically help their patients stick to their prescription regimens, according to a new study led by researchers at the University of Pittsburgh School of Pharmacy. 

September 15, 2014

Thanks to the Centers for Medicare and Medicaid Services’ Five-Star Quality Rating System, the diabetes community stands to play a significant role in how pharmacies think about their patients and their medication adherence programs. 

September 15, 2014

Managing such chronic conditions as diabetes has become a core competency among many retail pharmacies. It dovetails well with the retail pharmacy industry’s goal to become a destination center for patients proactively seeking to improve their health and wellness.

September 15, 2014

Mylan announced that its subsidiary, Mylan Labs Limited, has signed an agreement with Gilead Science under which Mylan has been licensed the non-exclusive rights to manufacture and distribute sofosbuvir and the investigational single-tablet regimen of ledipasvir/sofosbuvir in 91 developing countries. 

September 11, 2014

Par Pharmaceutical Cos. earlier this week resumed shipping dexmedetomidine hydrochloride (HCl) injection, EQ 100 mcg base/mL, the generic form of Hospira's Precedex injection. 

September 10, 2014

The Food and Drug Administration recently announced the availability of the “Purple Book,” which lists biological products in much the same way that the "Orange Book" lists pharmaceuticals. 

September 10, 2014

Kmart has announced that its Kmart Pharmacy, located at 901 US 27 North, Sebring, Fla., was the subject of a data incident on or around May 27, 2012.
 


September 9, 2014

Attorney General Eric Holder announced a new Drug Enforcement Administration regulation that would allow pharmacies and other authorized collectors to serve as authorized drop-off sites for unused prescription drugs.

September 9, 2014

Giant Food of Landover on Tuesday introduced Rx Timer Cap, an electronic cap that is an alternative to the traditional prescription medication caps. 

September 9, 2014

The Food and Drug Administration is on pace to match or exceed the 39 novel new medicines approved in 2012.

September 8, 2014

Camber Consumer Care, which focuses on both consumer care and prescription-to-OTC switch products, introduced new executives to its staff. 

September 8, 2014

Mylan is now free to resume distribution of its generic Precedex product (dexmedetomidine hydrochloride injection) to customers, effective immediately. 

September 8, 2014

Silvergate Pharmaceuticals on Monday announced that the Food and Drug Administration approved Epaned (enalapril maleate Powder for oral solution) for the treatment of symptomatic heart failure, as well as the treatment of asymptomatic left ventricular dysfunction. 

September 8, 2014

QS/1, a healthcare automation solutions provider, on Monday announced that it now offers Veridikal Intelligence and Veridikal’s Reconciliation program to the pharmacies it serves. The program includes pre/post editing, EDI support, 835 processing, forensic auditing and reconciliation. 

September 4, 2014

The Drug Enforcement Administration National Prescription Drug Take-Back Day collection site locator is now available online, the National Association of Boards of Pharmacy reported Wednesday.

September 4, 2014

Kline Group reported positive signs of 2013 growth across the over-the-counter sector in its recently published Nonprescription Drugs USA study, according to a blog posted Monday

September 4, 2014

Rite Aid on Thursday reported a 3.2% lift in sales for the 26 weeks ended Aug. 30, ringing in $12.9 billion. 

 

September 4, 2014

Teva Pharmaceutical on Thursday announced the launch of generic Baraclude (entecavir) tablets in 0.5-mg and 1-mg dosage strengths. The company was the first to file, giving it 180 days of marketing exclusivity for the drug. 

September 3, 2014

CVS Caremark announced today that it is changing its corporate name to CVS Health to reflect its broader healthcare commitment and its expertise in driving the innovations needed to shape the future of health.

September 3, 2014

Teva Pharmaceutical on Wednesday announced that a positive judgment has been given by the U.K. High Court in support of Teva's case against AstraZeneca relating to the validity of EP 1,085,877 covering the SMART (Single inhaler Maintenance And Reliever Therapy) indication for AstraZeneca's fixed dose formoterol/budesonide combination product, Symbicort.

September 2, 2014

The asthma treatment market value will grow from approximately $15.9 billion in 2013 across eight major countries — the United States, United Kingdom, France, Germany, Spain, Italy, Japan and Australia — to $23.1 billion by 2023, according to research and consulting firm GlobalData.